Tambunan, M.B., Suwarni, L., Setiawati, L., Mardjan, M. Β· Psikostudia: Jurnal Psikologi Β· 2022
In a quasi-experimental trial of 22 COVID-19-positive patients in Pontianak, Indonesia, EFT was associated with significant reductions in anxiety, depression, and insomnia scores (p<0.05) compared with no added intervention.
If findings like these hold up in larger trials, the promise is simple: a low-cost, self-administered tool that could reach people struggling with anxiety who can't easily access traditional care β at home, between appointments, or where there aren't enough clinicians to go around.
The natural next step: a larger sample to confirm the effect.
| Design | Controlled trial |
|---|---|
| Participants | 22 people |
| Population | People confirmed COVID-19 positive in isolation areas of Pontianak City, Indonesia (June 2021) |
| Comparison group | no intervention |
| Outcome measures | anxiety scale, depression scale, insomnia scale |
| Journal | Psikostudia: Jurnal Psikologi |
| Year | 2022 |
| Country | Indonesia |
| Language | Indonesian |
| Method | EFT / tapping |
| Publication type | Study / trial |
| Verification | β Confirmed against the primary source |
Tambunan, M.B., Suwarni, L., Setiawati, L., & Mardjan, M. (2022). EFT (emotional freedom technique) as an alternative therapy to reduce anxiety disorders and depression in people who are positive covid-19. Psikostudia: Jurnal Psikologi. https://doi.org/10.30872/psikostudia.v11i1.7104
This record is part of the Tapping Evidence Base β an openly-sourced, fully-referenced directory of the research on EFT/tapping. Explore more studies on Anxiety Β· Depression Β· Sleep & Insomnia
A ready-made graphic β right-click or long-press to save the image.